title: Application of key events analysis to chemical carcinogens and noncarcinogens.
abstract: The existence of thresholds for toxicants is a matter of debate in chemical risk assessment and regulation. Current risk assessment methods are based on the assumption that, in the absence of sufficient data, carcinogenesis does not have a threshold, while noncarcinogenic endpoints are assumed to be thresholded. Advances in our fundamental understanding of the events that underlie toxicity are providing opportunities to address these assumptions about thresholds. A key events dose-response analytic framework was used to evaluate three aspects of toxicity. The first section illustrates how a fundamental understanding of the mode of action for the hepatic toxicity and the hepatocarcinogenicity of chloroform in rodents can replace the assumption of low-dose linearity. The second section describes how advances in our understanding of the molecular aspects of carcinogenesis allow us to consider the critical steps in genotoxic carcinogenesis in a key events framework. The third section deals with the case of endocrine disrupters, where the most significant question regarding thresholds is the possible additivity to an endogenous background of hormonal activity. Each of the examples suggests that current assumptions about thresholds can be refined. Understanding inter-individual variability in the events involved in toxicological effects may enable a true population threshold(s) to be identified.
authors.affiliation: Department of Experimental Medicine and Toxicology, Imperial College London, London W12 0NN, UK.
authors.forename: Alan R
authors.initials: AR
authors.lastname: Boobis
authors.forename: George P
authors.initials: GP
authors.lastname: Daston
authors.forename: R Julian
authors.initials: RJ
authors.lastname: Preston
authors.forename: Stephen S
authors.initials: SS
authors.lastname: Olin
mesh_terms: D000465:Algorithms; D002273:Carcinogens / Q000493:pharmacokinetics* / Q000633:toxicity*; D004249:DNA Damage; D004261:DNA Replication / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D052244:Endocrine Disruptors / Q000493:pharmacokinetics / Q000633:toxicity; D005506:Food Contamination; D011634:Public Health; D018570:Risk Assessment; D012959:Socioeconomic Factors
chemical_list: D002273:Carcinogens; D052244:Endocrine Disruptors
references.citation: Nature. 2007 Mar 8;446(7132):153-8
references.pmid: 17344846
references.citation: Toxicol Appl Pharmacol. 1984 May;73(3):511-24
references.pmid: 6719466
references.citation: Cell. 1990 Jun 1;61(5):759-67
references.pmid: 2188735
references.citation: Toxicol Appl Pharmacol. 2006 Jun 15;213(3):267-81
references.pmid: 16630638
references.citation: Toxicology. 2002 Dec 27;181-182:115-20
references.pmid: 12505295
references.citation: Biol Pharm Bull. 2005 Jul;28(7):1221-3
references.pmid: 15997102
references.citation: Lab Invest. 1967 Apr;16(4):591-603
references.pmid: 4290484
references.citation: Risk Anal. 1994 Jun;14(3):333-8
references.pmid: 7518093
references.citation: Risk Anal. 2007 Dec;27(6):1535-51
references.pmid: 18093051
references.citation: Fed Regist. 1985 Dec 4;50(233):49760-2
references.pmid: 11645578
references.citation: Mutat Res. 1999 Mar 8;424(1-2):237-47
references.pmid: 10064864
references.citation: Arch Toxicol. 2006 Dec;80(12):797-803
references.pmid: 16710696
references.citation: Environ Health Perspect. 2004 Nov;112(16):1589-606
references.pmid: 15598610
references.citation: Drug Metab Dispos. 2004 Jul;32(7):727-33
references.pmid: 15205388
references.citation: Food Chem Toxicol. 2006 Oct;44(10):1636-50
references.pmid: 16891049
references.citation: J Proteome Res. 2008 Feb;7(2):497-503
references.pmid: 18179164
references.citation: J Toxicol Environ Health A. 2004 Apr 9;67(7):537-53
references.pmid: 15129551
references.citation: Mutagenesis. 2006 May;21(3):173-8
references.pmid: 16613912
references.citation: Int J Toxicol. 2003 Jan-Feb;22(1):25-33
references.pmid: 12573946
references.citation: Drug Metab Dispos. 1981 Jul-Aug;9(4):334-9
references.pmid: 6114833
references.citation: Toxicol Appl Pharmacol. 1983 Sep 30;70(3):480-5
references.pmid: 6636176
references.citation: Toxicology. 2004 May 20;198(1-3):239-48
references.pmid: 15138047
references.citation: Toxicol Appl Pharmacol. 1998 Apr;149(2):217-25
references.pmid: 9571991
references.citation: Crit Rev Toxicol. 2003;33(6):591-653
references.pmid: 14727733
references.citation: Biochem Pharmacol. 1998 Aug 1;56(3):377-87
references.pmid: 9744576
references.citation: Toxicol Lett. 2005 Nov 15;159(2):182-91
references.pmid: 15994032
references.citation: Toxicol Sci. 1998 Nov;46(1):61-74
references.pmid: 9928669
references.citation: PLoS One. 2009;4(2):e4584
references.pmid: 19240792
references.citation: J Biochem. 1991 Oct;110(4):559-65
references.pmid: 1778977
references.citation: J Appl Toxicol. 2004 May-Jun;24(3):203-10
references.pmid: 15211614
references.citation: Annu Rev Genomics Hum Genet. 2008;9:387-402
references.pmid: 18576944
references.citation: Toxicol Ind Health. 1999 Jan-Mar;15(1-2):48-64
references.pmid: 10188191
references.citation: Toxicol Sci. 2008 Dec;106(2):312-8
references.pmid: 18791183
references.citation: Arch Toxicol. 1997;71(10):638-45
references.pmid: 9332701
references.citation: Toxicology. 2003 May 3;187(2-3):101-15
references.pmid: 12699900
references.citation: Biochim Biophys Acta. 2006 May-Jun;1757(5-6):509-17
references.pmid: 16829228
references.citation: J Toxicol Environ Health A. 2007 Nov;70(22):1936-45
references.pmid: 17966065
references.citation: Mol Pharmacol. 1997 Mar;51(3):370-6
references.pmid: 9058590
references.citation: Toxicol Sci. 2005 Aug;86(2):396-416
references.pmid: 15901920
references.citation: Mt Sinai J Med. 2006 Jul;73(4):657-72
references.pmid: 16878272
references.citation: J Pharmacol Exp Ther. 2003 Oct;307(1):402-7
references.pmid: 14500779
references.citation: Environ Health Perspect. 1986 Nov;69:301-5
references.pmid: 3816733
references.citation: Cancer Lett. 1996 Jun 24;104(1):71-8
references.pmid: 8640749
references.citation: Toxicol Appl Pharmacol. 1983 Sep 30;70(3):467-79
references.pmid: 6636175
references.citation: Environ Health Perspect. 2009 Feb;117(2):283-7
references.pmid: 19270800
references.citation: Cell Biochem Biophys. 2009;53(1):17-31
references.pmid: 19034694
references.citation: Hum Exp Toxicol. 2001 Jul;20(7):321-7
references.pmid: 11530830
references.citation: Biochem Pharmacol. 1997 Mar 21;53(6):765-71
references.pmid: 9113097
references.citation: Chem Biol Interact. 1981 Oct;37(1-2):207-17
references.pmid: 7285244
references.citation: Fundam Appl Toxicol. 1996 Jul;32(1):109-25
references.pmid: 8812246
references.citation: Toxicol Appl Pharmacol. 1984 Jan;72(1):159-68
references.pmid: 6143425
references.citation: Physiol Genomics. 2003 Oct 17;15(2):127-41
references.pmid: 12915738
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 2004 Jan;369(1):89-104
references.pmid: 14574440
references.citation: Novartis Found Symp. 2007;282:3-25; discussion 25-8, 212-8
references.pmid: 17913221
references.citation: Biochem Pharmacol. 1987 Apr 1;36(7):1041-52
references.pmid: 3566800
references.citation: Environ Res. 2006 Jan;100(1):93-9
references.pmid: 16256101
references.citation: Toxicol Sci. 2007 Jun;97(2):467-90
references.pmid: 17351261
references.citation: Methods Mol Biol. 2006;316:35-48
references.pmid: 16671399
references.citation: Toxicol Appl Pharmacol. 1999 Oct 15;160(2):120-6
references.pmid: 10527910
references.citation: Regul Toxicol Pharmacol. 2001 Oct;34(2):146-52
references.pmid: 11603957
references.citation: Annu Rev Genet. 2004;38:445-76
references.pmid: 15568983
references.citation: Biochem Biophys Res Commun. 1988 Nov 30;157(1):55-60
references.pmid: 2904264
references.citation: Carcinogenesis. 1998 Jan;19(1):187-93
references.pmid: 9472711
references.citation: J Appl Toxicol. 2005 Jul-Aug;25(4):310-7
references.pmid: 16025433
references.citation: Biochem Biophys Res Commun. 1977 Dec 7;79(3):684-91
references.pmid: 597296
references.citation: Toxicol Sci. 2004 Jul;80(1):193-202
references.pmid: 15084756
references.citation: Chem Res Toxicol. 2008 Jan;21(1):253-65
references.pmid: 18161944
references.citation: Cell. 2000 Jan 7;100(1):57-70
references.pmid: 10647931
references.citation: Crit Rev Toxicol. 2008;38(2):87-96
references.pmid: 18259981
references.citation: Toxicol Appl Pharmacol. 1985 Jun 15;79(1):166-74
references.pmid: 4049404
references.citation: Toxicol Sci. 2000 Dec;58(2):366-76
references.pmid: 11099648
references.citation: Crit Rev Food Sci Nutr. 2009 Sep;49(8):682-9
references.pmid: 19690994
references.citation: Life Sci. 1978 Sep 11;23(10):1067-72
references.pmid: 713686
references.citation: Nature. 2009 Jan 1;457(7225):36-7
references.pmid: 19122629
references.citation: Crit Rev Toxicol. 2006 Nov-Dec;36(10):781-92
references.pmid: 17118728
references.citation: Drug Metab Dispos. 1984 May-Jun;12(3):304-8
references.pmid: 6145557
references.citation: Cancer Res. 2007 Apr 15;67(8):3904-11
references.pmid: 17440105
references.citation: Toxicol Appl Pharmacol. 1986 Apr;83(2):294-314
references.pmid: 3961817
references.citation: Hepatology. 1989 Oct;10(4):437-46
references.pmid: 2673969
references.citation: Fundam Appl Toxicol. 1994 Jan;22(1):90-102
references.pmid: 8125218
references.citation: Crit Rev Toxicol. 2005 Oct-Nov;35(8-9):673-83
references.pmid: 16417034
references.citation: Biochem Pharmacol. 1992 Apr 15;43(8):1876-9
references.pmid: 1575782
references.citation: Environ Health Perspect. 2005 Sep;113(9):1164-71
references.pmid: 16140622
references.citation: Eur J Cancer. 2008 Dec;44(18):2737-41
references.pmid: 18977654